A randomized trial of the effects of rosiglitazone and metformin on inflammation and subclinical atherosclerosis in patients with type 2 diabetes

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

Irene Stratton · BMJ · 2000 · 9K citations · Full text

Medicine, Chronic Disease Prevention, Internal Medicine +17

C-Reactive Protein Levels and Outcomes after Statin Therapy

Paul M. Ridker, Christopher P. Cannon, David A. Morrow et al. · New England Journal of Medicine · 2005 · 2.3K citations · Full text

Life Sciences, Clinical Sciences, Immunology +14

Statin Therapy, LDL Cholesterol, C-Reactive Protein, and Coronary Artery Disease

Steven E. Nissen, E. Murat Tuzcu, Paul Schoenhagen et al. · New England Journal of Medicine · 2005 · 1.3K citations

Medicine, Cardiology, Pharmacotherapy +17

The Role of Carotid Arterial Intima-Media Thickness in Predicting Clinical Coronary Events

Howard N. Hodis · Annals of Internal Medicine · 1998 · 1.2K citations

Veterinary Medicine, Cardiology, Surgery +17

Effect of Rosiglitazone Treatment on Nontraditional Markers of Cardiovascular Disease in Patients With Type 2 Diabetes Mellitus

Steven M. Haffner, Andrew S. Greenberg, Wayde M. Weston et al. · Circulation · 2002 · 879 citations · Full text

Medicine, Internal Medicine, Pharmacology +15